Home » Research » Funding Opportunities » Award Recipients
SARC has awarded the following recipients the SARC Career Development Award. We are proud to support these young investigators as they begin their careers in the field of sarcoma.
Instructor
Sarcoma Medical Oncology, University of Texas MD Anderson Cancer CenterView details
Assistant Member, St. Jude Faculty
St. Jude Children’s Research Hospital
AWARD TITLE – Investigation of SMARCAL1: A Novel Vulnerability in MYC-Amplified Osteosarcoma
View details
Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School
AWARD TITLE – Targeting cell cycle dysregulation in GIST
Radiation Oncologist, Translational Scientist
Department of Radiation Oncology, Division of Cellular and Molecular Oncology, UCLA
AWARD TITLE – Uncovering the role of myeloid cells in the anti-tumor immune response of undifferentiated pleomorphic sarcoma
Stanford University School of Medicine
AWARD TITLE – A Novel Chimeric Antigen Receptor T-cell Targeting B7-H3 for the Treatment of Pediatric Sarcomas
Research, Clinical Fellow
Division of Oncology, Washington University School of Medicine
AWARD TITLE – βIII-spectrin as a biomarker and therapeutic target for Malignant Peripheral Nerve Sheath Tumors
Associate Professor of Medicine, Sarcoma Program Director
Knight Cancer Institute, Translational Oncology Program, Oregon Health & Sciences University
AWARD TITLE – CDK4 inhibition in a molecularly-selected population of sarcomas
Pediatric Oncology, Johns Hopkins University, National Cancer Institute
AWARD TITLE – Study of circulating tumor cells and circulating tumor DNA in a novel orthotopic implantation/amputation model system of Ewing’s sarcoma that generates spontaneous metastases
Assistant Professor
Department of Pediatrics, Division of Hematology/Oncology, Duke University
AWARD TITLE – Identify a signaling pathway shared between Kras and injury-induced sarcomas that can be targeted in patients
Departments of Biomedical Informatics and Internal Medicine, Division of Medical Oncology
AWARD TITLE – Predicting Doxorubicin Sensitivity in Dedifferentiated Liposarcoma
Medical Oncologist
Department of Medical Oncology, Léon-Bérard Center
AWARD TITLE – Dystrophin inactivation in GIST
Department of Internal Medicine, Department of Biomedical Informatics, Ohio State University
AWARD TITLE – Development of a sarcoma tumor registry as platform for translational research
Research Fellow
Translational Sarcoma Research Program, Vall d’Hebron Hospital
AWARD TITLE – Evaluation of the contributions of candidate RMS-relevant genes/pathways in RMS malignancy
Physician
Internal Medicine/Pediatrics, Pediatric Hematology & Oncology, Dana Farber Cancer Institute
Associate Professor
Pediatrics, Harvard Medical School
AWARD TITLE – Reversing the roles of misdirected chromatin remodeling in human synovial sarcoma
Clinical Fellow
Pediatric Oncology, Johns Hopkins, National Cancer Institute
AWARD TITLE – Identifying novel therapies in pediatric rhabdomyosar-coma using high-output screening for inhibitors of the PAX-FOXO1 Oncogenic Transcription Factor
Professor of Medicine, Sarcoma Program Director
Department of Pediatrics, Washington University in St. Louis, MO
AWARD TITLE – Exploiting arginnosucci-nate synthase 1 deficiency in sarcoma
Scientist, Associate Professor
Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School in Boston, MA
AWARD TITLE – Genome-wide functional characteriza-tion of GIST: Strategies to maximize kinase-inhibitor response
Acting Instructor
University of Washington, Fred Hutchinson Cancer Research Center
AWARD TITLE – Adoptive T-cell therapy for patients with metastatic sarcoma
Surgical Oncology Fellow
MD Anderson Cancer Center
AWARD TITLE – The role of the P13K/AKT/mTOR pathway in radiation associated sarcoma (RAS)
Pediatric Oncologist
Children’s Hospital of Philadelphia
AWARD TITLE – Development of a Small Molecule Therapy Targeting EWS-FLI1
Pediatric Hematologist and Oncologist
Huntsman Cancer Institute, University of Utah
AWARD TITLE – Novel genomic approach to risk-stratify and identify relapse-associated copy number alterations in Ewing’s sarcoma
Senior Clinical Lecturer, Honorary Consultant Medical Oncologist
University College London Hospital
AWARD TITLE – Anchorage-independent conditions as a model for micrometasta-tic disease in osteosarcoma
Physician-Scientist
Department of Sarcoma Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center
AWARD TITLE – Targeted therapy of Ewing’s Sarcoma via IGF – 1R signaling cascade